Oscar Health Inc. (OSCR) Tops Q3 EPS by 20c

Oscar Health Inc. (NYSE: OSCR) reported Q3 EPS of ($0.29), $0.20 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.41 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Oscar Health Inc (OSCR) PT Raised to $48 at Piper Sandler
• Barclays Upgrades Allegro (AL0:GR) to Overweight
• Ipsen names Mariette Finet to its board of directors